Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Cochlear ( (AU:COH) ).
Cochlear Limited has announced that it will release its financial results for the fiscal year 2025 on August 15, 2025. The company will host a presentation accessible to analysts and media via webcast or conference call. This announcement is significant as it provides stakeholders with insights into the company’s financial performance and strategic direction, potentially impacting its market position and investor relations.
The most recent analyst rating on (AU:COH) stock is a Sell with a A$272.00 price target. To see the full list of analyst forecasts on Cochlear stock, see the AU:COH Stock Forecast page.
More about Cochlear
Cochlear Limited is a company operating in the medical device industry, primarily focused on the development and distribution of implantable hearing solutions. It is known for its cochlear implants, which are designed to help individuals with severe to profound hearing loss. The company has a significant market presence and is dedicated to improving hearing outcomes for its users.
YTD Price Performance: 8.79%
Average Trading Volume: 176,600
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$20.46B
For an in-depth examination of COH stock, go to TipRanks’ Overview page.